Top Markets
#1 COTI COTI +38.86%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +32.35%
#3 Fabric Protocol Fabric Protocol +30.24%
#4 GALA GALA +30.05%
#5 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +29.48%
#6 Bitcoin Cash Bitcoin Cash +29.01%
#7 Tutorial Tutorial +28.70%
#8 Talus Network Talus Network +25.87%
#9 Zora Zora +24.18%
#10 Magma Finance Magma Finance +24.04%
Coin of the day
COTI COTI
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Rangering i aksjer #24450
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Aksjekurs
$0.78611575
Markedsverdi
$60.45M
Endring (1 dag)
0.00%
Endring (1 år)
-12.06%
Land
NO
Handel Lytix Biopharma AS (LYTIX)

Kategori

Healthcare
Inntekter for Lytix Biopharma AS (LYTIX)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Lytix Biopharma AS er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Lytix Biopharma AS fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH